Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Cardiology Journal
MENU
Shortcuts Submit an article CJ Guide for Authors (new) Recent articles Special collections Ahead Of Print APIS-S Online Calculator OCT Contrast Calculator Reviewers 2022

open access

Vol 18, No 1 (2011)
How to do
Submitted: 2013-01-14
Published online: 2011-02-08
View PDF Download PDF file
Get Citation

Optimal strategies for the management of antiplatelet and anticoagulation medications prior to cardiac device implantation

Christine Tompkins, Charles A. Henrikson
Cardiol J 2011;18(1):103-109.

open access

Vol 18, No 1 (2011)
How to do
Submitted: 2013-01-14
Published online: 2011-02-08

Abstract

Choosing the optimal management strategy for antiplatelet and anticoagulation medications at the time of cardiac device implantation can be challenging. Simply withholding or reversing these medications puts patients at risk of subsequent thromboembolic events. Equally, continuing these medications may unnecessarily increase the risk of bleeding complications. This article summarizes recent findings and provides compelling evidence challenging current recommendations outlined by various professional organizations. (Cardiol J 2011; 18, 1: 103-109)

Abstract

Choosing the optimal management strategy for antiplatelet and anticoagulation medications at the time of cardiac device implantation can be challenging. Simply withholding or reversing these medications puts patients at risk of subsequent thromboembolic events. Equally, continuing these medications may unnecessarily increase the risk of bleeding complications. This article summarizes recent findings and provides compelling evidence challenging current recommendations outlined by various professional organizations. (Cardiol J 2011; 18, 1: 103-109)

Full Text:

View PDF Download PDF file
Get Citation

Keywords

pacemaker; implantable cardioverter-defibrillator; complications; anticoagulation

About this article
Title

Optimal strategies for the management of antiplatelet and anticoagulation medications prior to cardiac device implantation

Journal

Cardiology Journal

Issue

Vol 18, No 1 (2011)

Pages

103-109

Published online

2011-02-08

Page views

577

Article views/downloads

1506

Bibliographic record

Cardiol J 2011;18(1):103-109.

Keywords

pacemaker
implantable cardioverter-defibrillator
complications
anticoagulation

Authors

Christine Tompkins
Charles A. Henrikson

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl